Current prognostic indicators for GBM widely used include Karnofsky performance scale (KPS) score, tumour resection extent, and O6‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation status [3]. This evidence concerns the gene MGMT and neoplasm.